BATF2 and central nervous system cancer: Interestingly, Cell Counting Kit-8 analyses demonstrated that both overexpression and downregulation of BATF2 in U251, U87-MG, U118-MG, and A172 glioma cells did not affect cell viability in vitro (Fig. S3A–D).